Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$973000.0.

  • Treace Medical Concepts' Change in Inventory fell 14172.38% to -$973000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 11529.48%. This contributed to the annual value of $10.0 million for FY2024, which is 164.5% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Change in Inventory is -$973000.0, which was down 14172.38% from $4.5 million recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Change in Inventory high stood at $6.6 million for Q1 2024, and its period low was -$4.4 million during Q4 2024.
  • Over the past 5 years, Treace Medical Concepts' median Change in Inventory value was $2.3 million (recorded in 2024), while the average stood at $1.8 million.
  • In the last 5 years, Treace Medical Concepts' Change in Inventory surged by 874516.13% in 2022 and then plummeted by 640149.25% in 2024.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Change in Inventory stood at $31000.0 in 2021, then soared by 8745.16% to $2.7 million in 2022, then plummeted by 102.44% to -$67000.0 in 2023, then tumbled by 6401.49% to -$4.4 million in 2024, then soared by 77.66% to -$973000.0 in 2025.
  • Its Change in Inventory stands at -$973000.0 for Q3 2025, versus $4.5 million for Q2 2025 and -$1.3 million for Q1 2025.